IRIS
CINELLU, Maria Agostina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.342
EU - Europa 2.686
AS - Asia 1.707
SA - Sud America 18
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
AN - Antartide 1
Totale 8.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.307
UA - Ucraina 1.194
CN - Cina 1.099
SG - Singapore 508
SE - Svezia 436
DE - Germania 404
IT - Italia 211
FI - Finlandia 192
GB - Regno Unito 126
CA - Canada 33
BE - Belgio 31
FR - Francia 23
TR - Turchia 21
KR - Corea 15
IN - India 13
BR - Brasile 11
IR - Iran 11
AU - Australia 10
IE - Irlanda 9
CZ - Repubblica Ceca 8
NL - Olanda 8
JP - Giappone 7
EU - Europa 6
RO - Romania 5
RU - Federazione Russa 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BD - Bangladesh 4
HK - Hong Kong 4
ID - Indonesia 4
PL - Polonia 4
PT - Portogallo 4
SA - Arabia Saudita 4
AT - Austria 3
BY - Bielorussia 3
CH - Svizzera 3
ES - Italia 3
GR - Grecia 3
IQ - Iraq 3
MA - Marocco 3
PK - Pakistan 3
TN - Tunisia 3
ZA - Sudafrica 3
LB - Libano 2
MD - Moldavia 2
MN - Mongolia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
LV - Lettonia 1
MC - Monaco 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
TW - Taiwan 1
Totale 8.786
Salva come PNG Salva come JPEG
Città #
Chandler 1.123
Jacksonville 727
Singapore 393
Princeton 369
Nanjing 272
Dearborn 227
Wilmington 174
Ann Arbor 138
Boardman 106
Nanchang 102
Sassari 96
Beijing 92
Woodbridge 91
Shanghai 75
Washington 72
Shenyang 67
Hebei 64
Changsha 52
Tianjin 49
Mountain View 48
Kunming 46
Jiaxing 45
Andover 41
Hangzhou 35
Jinan 32
Santa Clara 32
Brussels 31
Ashburn 28
Houston 28
Zhengzhou 28
Ningbo 26
San Mateo 26
Toronto 26
Leawood 21
San Francisco 19
Norwalk 18
Augusta 17
Guangzhou 16
Monmouth Junction 15
Seoul 15
Taizhou 14
Florence 13
Izmir 13
Helsinki 12
Tappahannock 12
Auburn Hills 11
Los Angeles 11
Dallas 10
Ardabil 9
Dublin 9
Perugia 9
Camerino 8
Frankfurt am Main 7
Lanzhou 7
Falls Church 6
Fuzhou 6
Changchun 5
Edinburgh 5
London 5
New York 5
Tokyo 5
West Jordan 5
Brno 4
Cedar Knolls 4
Chicago 4
Haikou 4
Munich 4
Riyadh 4
Romola 4
Amsterdam 3
Cagliari 3
Canberra 3
Clifton 3
Dhaka 3
Harbin 3
Hefei 3
Manchester 3
Markham 3
Melbourne 3
Mumbai 3
Olomouc 3
Paris 3
Rabat 3
Rome 3
Warsaw 3
Almere Stad 2
Assemini 2
Baghdad 2
Beirut 2
Berlin 2
Bratislava 2
Chisinau 2
Fairfield 2
Gauteng 2
Jinhua 2
Lasino 2
Lima 2
Madrid 2
Milan 2
Minsk 2
Totale 5.175
Salva come PNG Salva come JPEG
Nome #
1,1' BIS(DIPHENYLPHOSPHINO)FERROCENE COMPLEXES OF PLATINUM(II) AND PLATINUM(I) - CRYSTAL AND MOLECULAR-STRUCTURE OF [(FE(ETA-5-C5H4PPH2)PT(MU-H)(MU-CO)PT(FE(ETA-5-C5H4PPH2)2)][BF4]-0.5H2O 118
New complexes of palladium(II) with chelating heterocyclic nitrogen ligands. Characterization and catalytic activity in CO-styrene copolimerization. Crystal structure of [Pd(bipy)2][BAr’4]2, Ar’ = [3,5-(CF3)2C6H3] 103
Gold(III) adducts of 2-vinyl- and 2-ethylpyridine and cyclometallated derivatives of 2-vinylpyridine: Crystal structure of the cyclometallated derivative [Au(k(2)-C,N-CH(2)CH(Cl)-C(5)H(4)N)(PPh(3))Cl][PF(6)] RID D-3096-2011 92
Gold(III) Adducts with Chiral Pyridinyl-Oxazolines. Synthesis, Reactivity of the Coordinated Ligands and Structural Characterizations 84
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reaction with Model Proteins, Antiproliferative Properties. 81
The first gold(III) dinuclear cyclometallated derivatives with a single oxo bridge 75
Reaction of gold(III) oxo complexes with alkenes. Synthesis of unprecedented gold alkene complexes, [Au(N,N)(alkene)][PF6]. Crystal structure of [Au(bipy(ip))(eta(2)-CH2=CHPh)][PF6] (bipy(ip)=6-isopropyl-2,2 '-bipyridine) 73
Dinuclear platinum(II) complexes with bridging twofold deprotonated 2,2 ': 6 ',2 ''-terpyridine. New molecules with a 3,5-diplatinated-pyridyl inner core: [Pt-2(terpy-2H)(Me)(2)(L)(2)], [Pt-2(terpy-2H)(X)(2)(L)(2)] and [Pt-2(terpy-2H)(H)(2)(L)(2)] (L = neutral ligand; X = halide) - Crystal and molecular structure of [Pt-2(terpy-2H)(Cl)(2)(PPh3)(2)] RID D-3096-2011 73
Synthesis, Solution Behavior, Molecular and Supramolecular Structures of the Water- soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 73
N,C "Rollover" cyclometalated platinum(II) hydrides: Mono- and polynuclear derivatives 72
Assembly of symmetrical and unsymmetrical platinum(II) rollover complexes with bidentate phosphine ligands 71
Reactivity of Ph2P(O)py-2 with platinum(II) alkyl derivatives - Building-up of a chiral phosphorus atom through C,N-cyclometallation RID D-3096-2011 71
Gold-Alkyne Complexes 71
[Au2(phen2Me)2(?-O)2](PF6)2, a novel dinuclear gold(III) complex showing excellent antiproliferative properties 69
Rollover-assisted C(sp2)-C(sp3) bond formation 69
Cytotoxic Properties of a New Organometallic Platinum(II) Complex and its Gold(I) Heterobimetallic Derivatives 68
SYNTHESIS AND CHARACTERIZATION OF GOLD(III) ADDUCTS AND CYCLOMETALATED DERIVATIVES WITH 2-SUBSTITUTED PYRIDINES - CRYSTAL-STRUCTURE OF [AU(NC5H4(CME(2)C(6)H(4))-2)CL-2] 66
Electrochemical properties of gold(III) complexes with 2,2 '-bipyridine and oxygen ligands 65
ADDUCTS AND CYCLOMETALLATED DERIVATIVES OF PALLADIUM(II) WITH SOME 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF TRANS-DICHLOROBIS[7-CHLORO-1-(CYCLOPROPYLMETHYL)-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE]PALLADIUM(II) 64
Complessi di Oro(III) con leganti pincer NCN piridinici 63
New Variations on the Theme of Gold(III) C ∧ N ∧ N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization 63
Activation of a C-H bond in a pyridine ring. Reaction of 6-substituted 2,2 '-bipyridines with methyl and phenyl platinum(II) derivatives: N ',C(3)-"rollover" cyclometalation 63
Cyclometalated Platinum(II) hydrides with nitrogen ligands 62
Complessi pincer NCN di Au(III) quali possibili agenti antitumorali 62
Platinum(II), palladium(II) and gold(III) adducts and cyclometalated derivatives of 6-methoxy-2,2’-bipyridine: A comparative study 62
Gold(III) derivatives with a-diimines as potential antitumor agents: synthesis and characterization 62
Gold(III) derivatives with anionic oxygen ligands: mononuclear hydroxo, alkoxo and acetato complexes. Crystal structure of [Au(bpy)(OMe)(2)][PF6] 62
Electronic and steric effects in rollover C-H bond activation 61
Platinum(II)-Cyclometalated “Roll-over” Complexes with a Chiral Pinene-Derived 2,2'-Bipyridine 61
Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme 60
Palladium(II) and platinum(II) derivatives with N,O ligands 60
Chemistry, antiproliferative properties, tumor selectivity and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study 60
Selected Cytotoxic Gold Compounds cause Significant Inhibition of 20S Proteasome Catalytic Activities 60
Chiral cyclometalation of 6-(1-phenylbenzyl)-2,2’-bipyridine. 60
Synthesis of the first C-2 cyclopalladated derivatives of 1,3-bis(2-pyridyl)benzene. Crystal structures of [Hg(N-C-N)Cl], [Pd(N-C-N)Cl], and [Pd-2(N-C-N)(2)(mu-OAc)](2)[Hg2Cl6]. Catalytic activity in the heck reaction 59
Synthesis and Characterization of Gold(III) Adducts and Cyclometallated Derivatives with 6-Benzyl- and 6-Alkyl-2,2’-bipyridines 57
Cyclometalation of 2,2'-Bipyridine, Mono- and Dinuclear C,N Platinum(II) Derivatives 57
Reaction of Carbon Monoxide with Cyclometallated Complexes of Palladium(II) and Platinum(II) Derived from a Chiral Alkylbipyridine Ligand 57
Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays. 57
Dinuclear Gold(III) Complexes as Potential Anticancer Agents. Structure, Reactivity and Biological Profile of a Series of Gold(III) Oxo-Bridged Derivatives 56
Synthesis and Characterization of Square-planar Palladium(II), Platinum(II) and Rhodium(I) Complexes with a Chiral Pyridylphosphine Hybrid Ligand 56
Unusual Platinum Hydrides With Nitrogen Ligands 55
Palladium(II) and Platinum(II) Derivatives with Chiral 2,2'-Bipyridines. X-ray Structure of C18H15ClN2Pd; C- and N-intramolecular Coordination in a Six-membered Metallacycle 55
Mono and Dinuclear Gold(I) Complexes with Neutral and Deprotonated 1,4-Benzodiazepin-2-ones. Crystal and Molecular Structure of (L-H)Au(PPh3).Et2O, where L = 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one, NITRAZEPAM 55
Structural, theoretical and spectroscopic characterisation of a series of novel gold(I)-norbornene complexes supported by phenanthrolines: effects of the supporting ligand 55
Gold(III) Six-membered N^C^N Pincer Complexes: Synthesis, Structure, Reactivity and Theoretical Calculations 55
Metallation of unactivated methyl groups. Platinum(II) derivatives with 6-alkyl-2,2’-bipyridines 55
Large Effect of a Small Substitution: Competition of Dehydration with Charge Retention and Coulomb Explosion in Gaseous [(bipyR)Au(μ-O)2Au(bipyR)]2+ Dications 54
m-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2’-bipiridines. Synthesis, characterization and X-ray structures 54
Heterobimetallic rollover derivatives 54
Rollover cyclometalation with 2-(2’-Pyridyl)quinoline 53
Synthesis and Characterization of Palladium(II) and Platinum(II) Adducts and Cyclometalated Complexes of 6,6 '-Dimethoxy-2,2 '-bipyridine: C(sp(3))-H and C(sp(2))-H Bond Activations 53
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds. 53
Reactivity of 1,3-bis(2-pyridyl)benzene, N boolean AND CH boolean AND N, with gold(III) chlorides: salts, adducts and cyclometalated pincer derivatives. Crystal and molecular structures of [HN boolean AND CH boolean AND N][AuCl4], [Au(N boolean AND C boolean AND N)Cl][PF6] and [Au(N boolean AND C boolean AND N)Cl(PPh3)(2)][PF6] 53
Synthesis and properties of gold alkene complexes. Crystal structure of [Au(bipyoXyl)(g2-CH2=CHPh)](PF6) and DFT calculations on the model cation [Au(bipy)(g2-CH2=CH2)]+ 53
Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound. 52
Cytotoxic gold compounds showing selectivity between cancerous and normal cells: synthesis and biological characterization. 52
Comportamento catodico di addotti di Au(III) con 2,2’-bipiridine 52
FAB Mass Spectrometry of Palladium(II) Derivatives with 1,4-Benzodiazepin-2-ones: Evidence of the Stability of Cyclometallated Species 52
Synthesis of Au(III) complexes with non-symmetric NCN pincer-type ligands 52
Interaction of selected gold(III) complexes with DNA G quadruplexes 51
Sintesi e studio della reattività di complessi di Au con proprietà citotossiche 51
Synthesis, characterization and evaluation of gold complexes as anti microbial compounds 51
Auraoxetanes as Plausible Intermediates in the Oxidation of Alkenes by Oxygen- Transfer Reaction from Gold(III) Oxo Complexes. 51
[Au(pyb-H)(mnt)]: A novel gold(III) 1,2-dithiolene cyclometalated complex with antimicrobial activity (pyb-H = C-deprotonated 2-benzylpyridine; mnt = 1,2-dicyanoethene-1,2-dithiolate) 51
A Gold(III) Push-Pull Mixed-Ligand Complex for ICT Applications: Synthesis, Characterization, and DFT Investigation 51
The mode of action of anticancer gold-based drugs: a structural perspective. 50
C(3) aurated 1,4-benzodiazepin-2-ones. Synthesis and characterization. Crystal structure of (L)Au[P(C6H4CH3-4)(3)] (HL = 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, DIAZEPAM) 50
Step by step palladium mediated syntheses of new 2-(pyridin-2-yl)-6-R-nicotinic acids and esters RID D-3096-2011 50
Solution chemistry and cytotoxic properties of novel organogold(III) compounds 50
Reaction of Platinum(II) Derivatives with Bis(pyrazolyl)propane. Cleavage of a C(sp3)-N Bond in a Bis(pyrazolyl)alkane Promoted by Platinum(II) Derivatives. Crystal Structure of cis-Pt(pzH)2Cl2. (pzH = pyrazole) 50
Inhibition of Na+/K+-ATPase and cytotoxicity of a few selected gold(III) complexes. 50
Reactions of Gold(III) Oxo Complexes with Cyclic Alkenes 50
Complessi NCN di Oro(III) con leganti pincer aromatici con gruppi piridilici 50
mu-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2 '-bipyridines. Synthesis, characterization and X-ray structures 50
Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity and DNA binding properties 50
Metil derivati chirali di platino(II) con pyridine 2-sostituite 50
Mechanisms of cytotoxycity of selected organogold(III) compounds 49
Rollover Derivatives of 2,2’-bipyridines 49
ADDUCTS AND CYCLOMETALATED DERIVATIVES OF PALLADIUM(II) WITH 2-(1-METHYLBENZYL)PYRIDINE RID D-3096-2011 49
Cyclometallated Derivatives of Palladium (II) and Platinum (II) with 6-(t-Butyl)-2,2'-bipyridine 49
CYCLOMETALATED DERIVATIVES OF PLATINUM(II) DERIVED FROM 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF PT(L)(HL)CL (HL=7-CHLORO-1,3-DIHYDRO-1-METHYL-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE, DIAZEPAM), A MOLECULE CONTAINING A NEUTRAL AND A DEPROTONATED 1,4-BENZODIAZEPIN-2-ONE 48
Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipyc 48
Palladium(II) and platinum(II)-C-(3)-substituted 2,2 '-bipyridines RID D-3096-2011 48
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles. 48
Outstanding plasmodicidal properties within a small panel of metallic compounds: hints for the development of new metal-based antimalarials 48
Homo- and Hetero-Dinuclear C,N^N,C Cyclometallates 48
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study 48
The first pincer-aryl [M-(NCN)] complexes {M = Pd(II); Pt(II)} with chiral pyridine donors: Synthesis and catalytic activity in C-C bond formation 47
N^N^C Platinum(II) and Palladium(II) cyclometallates of 6,6’-diphenyl-2,2’-bipyridine, L. Crystal and molecular structure of [Pd(L-H)Cl] 47
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays 47
Replacement of the chloride ligand in [Au(C,N,N)Cl][PF6] cyclometallated complexes by C, N, O and S donor anionic ligands RID D-3096-2011 47
Chiral methyl derivatives of platinum(II) with 2-substituted pyridines 47
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 47
Synthesis of the first Pd(II), Pt(II) and Au(III) derivatives with 6,6’-dimethoxy-2,2’-bipyridine 47
Chemistry of Gold(III) Complexes with Nitrogen and Oxygen Ligands 47
Complessi mono e dinucleari di oro (i) e oro (iii): applicazioni in campo farmacologico e catalitico 46
Catalytic and Biological studies of Au(III) complexes with pyridinyl-oxazoline ligands 46
Potential antitumor gold drugs: DFT and XANES studies of local atomic and electronic structure 46
Intramolecular C(sp2)-H Bond Activation in 6,6'-Dimethoxy-2,2'-Bipyridine with Gold(III). Crystal and Molecular Structure of the First N',C(3) “Rollover” Cycloaurated Derivative 46
Totale 5.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.012 0 0 0 0 0 189 321 21 209 51 207 14
2020/20211.665 190 4 277 3 217 96 189 5 230 237 169 48
2021/2022939 163 9 3 7 6 10 52 71 93 48 87 390
2022/20232.028 215 116 27 385 222 349 10 238 313 13 86 54
2023/2024415 94 49 18 15 92 10 11 7 0 7 46 66
2024/2025804 34 43 281 95 223 128 0 0 0 0 0 0
Totale 8.849